Overview of the Carrier Screening Market
Roots Analysis has published a report on the global Carrier Screening market, This market research report delivers a detailed and up-to-date analysis of the industry, covering market size, share, growth trends, key drivers, restraints, opportunities, and competitive landscape. Designed for business leaders, investors, and analysts, the report provides actionable intelligence to support strategic planning, market entry decisions, and long-term investment strategies.
Key Findings of the Study:
In terms of geographical regions, North America currently holds the highest atrial fibrillation treatment devices market share ( nearly 50%) .
Market Size in 2026: $9.6 Billion
Estimated Market Size in 2035: $29.0 Billion
CAGR (2026-2035): 13.1%
North America: Largest market in 2026
Asia-Pacific: Fastest growing region
- To know more about other segments within Carrier Screening market, read here https://www.rootsanalysis.com/reports/carrier-screening-market.html
Carrier Screening Adoption in the Asia Pacific Region
Request for free sample, https://www.rootsanalysis.com/reports/carrier-screening-market/request-sample.html
Competitive Landscape
The Carrier Screening Market has multiple key players in the market, which are profiled in the report also-
- Eurofins Scientific
- Fulgent Genetics
- Invitae
- Illumina
- Luminex
- Gene By Gene
- Mount Sinai Genomics
- MedGenome
- Myriad Genetics
- Natera
- Otogenetics
- Opko Health
- Sema4 OpCo
- Quest Diagnostics
- Thermo Fisher Scientific
There are more key players involved in Carrier Screening market mentioned in the report
Key Market Segments
Carrier Screening Market Segmentation Insights
The market report provides comprehensive information on industrial players who are currently active across various segments of the industry as mentioned in the table below.
Carrier Screening Market: Report Attributes / Market Segmentation
One of the key objectives of the carrier screening market analysis was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The global market analysis report also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of carrier screening ( expanded carrier screening and targeted disease carrier screening ), type of disease ( cystic fibrosis, Tay-Sachs, Qaucher disease, sickle cell disease, spinal muscular atrophy and other medical conditions ), type of medical condition ( pulmonary conditions, hematological conditions, neurological conditions and other medical conditions ), type of technology ( DNA sequencing, polymerase chain reaction, microarrays and other technologies ), application area ( prenatal screening, preconception screening and newborn screening ), end-user ( hospitals, laboratories, physician offices & clinics and other end-users ), geographical region ( North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America ) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three carrier screening market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
▪ Expanded Carrier Screening
▪ Targeted Disease Carrier Screening
▪ Cystic Fibrosis
▪ Tay-Sachs
▪ Gaucher Disease
▪ Sickle Cell Disease
▪ Spinal Muscular Atrophy
▪ Other Diseases
▪ Pulmonary Conditions
▪ Hematological Conditions
▪ Neurological Conditions
▪ Other Medical Conditions
▪ DNA Sequencing
▪ Polymerase Chain Reaction
▪ Microarrays
▪ Other Technologies
▪ Prenatal Screening
▪ Preconception Screening
▪ Newborn Screening
▪ Hospitals, Laboratories
▪ Physician Offices & Clinics
▪ Other End-Users
▪ North America ( US, Canada and Mexico )
▪ Europe ( France, Germany, Italy, Spain, UK and Rest of Europe )
▪ Asia Pacific ( China, India, Japan, South Korea, and Rest of Asia Pacific )
▪ Middle East and North Africa ( Egypt, Saudi Arabia and United Arab Emirates )
▪ Latin America ( Argentina and Brazil )
▪ Eurofins Scientific
▪ Fulgent Genetics
▪ Invitae
▪ Illumina
▪ Luminex
▪ Gene By Gene
▪ Mount Sinai Genomics
▪ MedGenome
▪ Myriad Genetics
▪ Natera
▪ Otogenetics
▪ Opko Health
▪ Sema4 OpCo
▪ Quest Diagnostics
▪ Thermo Fisher Scientific
Key Questions Answered in the Report-
What does a carrier screening do?
How big is the carrier screening market?
What is the future outlook for carrier screening?
What is the growth rate of the carrier screening market?
Which regions holds the highest share of the carrier screening market?
How much does a carrier screening cost?
What is the purpose of screening?
What are the growth factors of the carrier screening market?
Who are the leading players in carrier screening industry?
To read more about key questions answered and market insights, you can refer to the full report by Roots Analysis, https://www.rootsanalysis.com/reports/carrier-screening-market.html
To learn more about this report, request a free sample copy
